Association between prostate size and the incidence of prostate cancer: a meta-analysis and review for urologists and clinicians
- PMID: 34024008
- DOI: 10.1007/s11255-021-02892-w
Association between prostate size and the incidence of prostate cancer: a meta-analysis and review for urologists and clinicians
Abstract
Purpose: To review the literature regarding any clinically significant association between prostate size and the incidence of prostate cancer (PCa). No previous review or meta-analysis has reported this clinical question.
Methods: A thorough literature review was performed using PubMed and applying the 'PRISMA' guidelines. Inclusion and exclusion criteria were defined.
Results: A total of 30 articles met the search criteria. Of these 30 articles, 27 reported an inverse correlation between prostate volume (PV) and incidence of biopsy-proven PCa. The remaining three articles provided no clear statistically significant results, and there was no study showing a direct or positive correlation between PV and the incidence of PCa.
Conclusion: This review and meta-analysis is the first report summarizing the literature on the clinical question of whether prostate size affects the incidence of PCa. Ninety percent of studies (27/30) show significant evidence supporting the hypothesis that prostate size may be protective of PCa. This review and the outlined discussion should encourage other clinical investigators to explore the relationship between PV and the incidence and aggressiveness of PCa. If future studies should confirm the hypothesis of the dynamic interactions between the different prostatic zones in a growing prostate, it will have relevant clinical implications on the management of BPH and PCa.
Keywords: BPH; Cancer; Incidence; Prostate; Size; Volume.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
MRI determined prostate volume and the incidence of prostate cancer on MRI-fusion biopsy: a systemic review of reported data for the last 20 years.Int Urol Nephrol. 2022 Dec;54(12):3047-3054. doi: 10.1007/s11255-022-03351-w. Epub 2022 Aug 30. Int Urol Nephrol. 2022. PMID: 36040649
-
Any Correlation Between Prostate Volume and Incidence of Prostate Cancer: A Review of Reported Data for the Last Thirty Years.Res Rep Urol. 2021 Oct 10;13:749-757. doi: 10.2147/RRU.S331506. eCollection 2021. Res Rep Urol. 2021. PMID: 34676178 Free PMC article. Review.
-
Prostate volume does not provide additional predictive value to prostate health index for prostate cancer or clinically significant prostate cancer: results from a multicenter study in China.Asian J Androl. 2020 Sep-Oct;22(5):539-543. doi: 10.4103/aja.aja_136_19. Asian J Androl. 2020. PMID: 31929198 Free PMC article.
-
Larger men have larger prostates: Detection bias in epidemiologic studies of obesity and prostate cancer risk.Prostate. 2017 Jun;77(9):949-954. doi: 10.1002/pros.23350. Epub 2017 Mar 27. Prostate. 2017. PMID: 28349547 Free PMC article.
-
Clinical Significance of Proliferative Inflammatory Atrophy in Negative Prostatic Biopsies.Prostate. 2016 Dec;76(16):1501-1506. doi: 10.1002/pros.23234. Epub 2016 Jul 12. Prostate. 2016. PMID: 27404228
Cited by
-
Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation.J Adv Res. 2024 Mar;57:135-147. doi: 10.1016/j.jare.2023.04.006. Epub 2023 Apr 14. J Adv Res. 2024. PMID: 37061215 Free PMC article.
-
Research on the mean maximum Young's modulus value as a new diagnostic parameter for prostate cancer.Sci Rep. 2024 Jul 22;14(1):16828. doi: 10.1038/s41598-024-68036-z. Sci Rep. 2024. PMID: 39039192 Free PMC article.
-
Cholesterol-Based Nanovesicles Enhance the In Vitro Cytotoxicity, Ex Vivo Intestinal Absorption, and In Vivo Bioavailability of Flutamide.Pharmaceutics. 2021 Oct 20;13(11):1741. doi: 10.3390/pharmaceutics13111741. Pharmaceutics. 2021. PMID: 34834155 Free PMC article.
-
2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review.Eur Urol. 2023 Aug;84(2):191-206. doi: 10.1016/j.eururo.2023.04.021. Epub 2023 May 16. Eur Urol. 2023. PMID: 37202314 Free PMC article.
-
Urinary symptoms and prostate cancer-the misconception that may be preventing earlier presentation and better survival outcomes.BMC Med. 2022 Aug 4;20(1):264. doi: 10.1186/s12916-022-02453-7. BMC Med. 2022. PMID: 35922801 Free PMC article.
References
-
- Ørsted DD, Bojesen SE (2013) The link between benign prostatic hyperplasia and prostate cancer. Nat Rev Urol 10(1):49–54 - DOI
-
- Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30 - DOI
-
- PRISMA (2021) http://www.prisma-statement.org/ Accessed 21 Feb 2021.
-
- Al-Azab R, Toi A, Lockwood G, Kulkarni GS, Fleshner N (2007) Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostatespecific antigen values between 2.0 and 9.0 ng/mL. Urology. 69(1):103–107 - DOI
-
- Al-Khalil S, Ibilibor C, Cammack JT, de Riese W (2016) Association of prostate volume with incidence and aggressiveness of prostate cancer. Res Rep Urol 26(8):201–205
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous